Recent advances in microneedles for tumor therapy and diagnosis
Source abstract
Abstract
Abstract Microneedles (MNs) as an efficient transdermal delivery tool have been widely developed in various fields due to their unique micro-tip structures and effective topical administration. In particular, there is a growing interest in oncology applications by MNs, which could realize convenient and effective tumor therapy and diagnosis through the corresponding design and manufacture of MNs, and eventually achieve the goal of better serving patients. This review aims to summarize the recent advances in MNs for tumor therapy, including MN-assisted chemotherapy, MN-assisted photothermal therapy, MN-assisted photodynamic therapy, MN-assisted gene therapy, MN-assisted immunotherapy, as well as some MN-assisted combination therapies, and also highlight the recent progress of MNs for tumor detection and diagnosis based on MN-assisted sampling devices and biosensors. Finally, the challenges and perspectives for the development of MNs for tumor therapy and diagnosis are discussed. It is highly expected that the well-designed MN system will become an attractive device for efficient treatment or diagnosis of tumors and contribute to the goal of combating tumors.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Fluorescence Microscopy Techniques · Advancements in Transdermal Drug Delivery · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Radiotherapy toxicity
2. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy10.1016/j.biomaterials.2016.01.008 ↗
3. Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review10.3390/ijms19010195 ↗
4. Optimizing the outcomes of pancreatic cancer surgery10.1038/s41571-018-0112-1 ↗
5. Mucoadhesive polymers for buccal drug delivery10.3109/03639045.2014.892959 ↗
6. Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs10.1016/j.biomaterials.2018.10.012 ↗
7. Microneedle patches as drug and vaccine delivery platform10.2174/0929867324666170526124053 ↗
8. Microneedles: a versatile strategy for transdermal delivery of biological molecules10.1016/j.ijbiomac.2017.12.027 ↗
9. Microneedle, bio-microneedle and bio-inspired microneedle: a review10.1016/j.jconrel.2017.02.011 ↗
10. Lecithin-based nanostructured gels for skin delivery: an update on state of art and recent applications10.1016/j.jconrel.2014.02.004 ↗
11. Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs)10.1016/j.ijpharm.2011.07.002 ↗
12. Microneedles: a smart approach and increasing potential for transdermal drug delivery system10.1016/j.biopha.2018.10.078 ↗
13. Considerations in the use of microneedles: pain, convenience, anxiety and safety10.1080/1061186X.2016.1200589 ↗
14. Microneedles: a new frontier in nanomedicine delivery10.1007/s11095-016-1885-5 ↗
15. Microneedles for drug delivery: trends and progress10.3109/10717544.2014.986309 ↗
16. Dissolving microneedles for transdermal drug delivery: advances and challenges10.1016/j.biopha.2017.07.019 ↗
17. Microneedles for transdermal drug delivery: a systematic review10.1080/03639045.2018.1539497 ↗
18. Microneedles: a potential strategy in transdermal delivery and application in the management of psoriasis10.1039/D0RA00735H ↗
19. Current Trends in Polymer Microneedle for Transdermal Drug Delivery
20. Solid silicon microneedles for drug delivery applications10.1007/s00170-016-9698-6 ↗
21. In-plane silicon microneedles with open capillary microfluidic networks by deep reactive ion etching and sacrificial layer based sharpening10.1016/j.sna.2019.04.008 ↗
22. Fabrication and characterization of gold-coated solid silicon microneedles with improved biocompatibility10.1007/s00170-018-2596-3 ↗
23. Controlled release of a model vaccine by nanoporous ceramic microneedle arrays10.1016/j.ijpharm.2015.06.025 ↗
24. Bioceramic microneedles with flexible and self-swelling substrate10.1016/j.ejpb.2015.06.016 ↗
25. Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses10.1016/j.ejpb.2019.02.002 ↗
26. Analysis of process parameters and performance test for fabricating stainless-steel metal microneedles
27. Fabrication of hollow metal microneedle arrays using a molding and electroplating method10.1557/adv.2019.147 ↗
28. Fabrication of coated polymer microneedles for transdermal drug delivery10.1016/j.jconrel.2017.03.383 ↗
29. Porous polymer microneedles with interconnecting microchannels for rapid fluid transport10.1039/C6RA07882F ↗
30. Biodegradable 3D printed polymer microneedles for transdermal drug delivery10.1039/C8LC00098K ↗
31. Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin10.1016/j.msec.2017.05.143 ↗
32. Identification of extrahepatic metastasis of hepatocellular carcinoma using indocyanine green fluorescence imaging10.1016/j.pdpdt.2019.01.031 ↗
33. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows10.1038/s41551-019-0494-0 ↗
34. Neural network based brain tumor detection using wireless infrared imaging sensor10.1109/ACCESS.2018.2883957 ↗
35. Post-operative perfusion and diffusion MR imaging and tumor progression in high-grade gliomas10.1371/journal.pone.0213905 ↗
36. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review10.1186/s13048-019-0503-7 ↗
37. Tumor markers in clinical practice: a review focusing on common solid cancers10.1159/000338393 ↗
38. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer10.1016/j.lungcan.2011.11.012 ↗
39. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association10.1007/s10120-013-0259-5 ↗
40. Galectin expression in cancer diagnosis and prognosis: a systematic review
41. Digital image analysis-based scoring system for endoscopic ultrasonography is useful in predicting gastrointestinal stromal tumors10.1007/s10120-019-00928-w ↗
42. Efficacy of endoscopic evaluation of acute radiation esophagitis during chemoradiotherapy with proton beam therapy boost for esophageal cancer10.1159/000500039 ↗
43. Retrospective evaluation of histopathological examinations in invasive ductal breast cancer of no special type: an analysis of 691 patients10.5114/aoms.2015.53964 ↗
44. Histopathological analysis of papillary thyroid carcinoma detected during ultrasound screening examinations in Fukushima10.1111/cas.13912 ↗
45. Improved pathological examination of tumors with 3D light-sheet microscopy10.1016/j.trecan.2018.03.003 ↗
46. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer10.1002/cam4.2286 ↗
47. Liquid biopsy in glioblastoma: opportunities, applications and challenges10.3390/cancers11070950 ↗
48. Metal–organic framework (MOF) hybrid as a tandem catalyst for enhanced therapy against hypoxic tumor cells10.1002/anie.201903475 ↗
49. A mesoporous nanoenzyme derived from metal–organic frameworks with endogenous oxygen generation to alleviate tumor hypoxia for significantly enhanced photodynamic therapy
50. Persistent regulation of tumor microenvironment via circulating catalysis of MnFe2O4@metal–organic frameworks for enhanced photodynamic therapy10.1002/adfm.201901417 ↗
51. Mesoporous silica nanoparticles as drug delivery vehicles in cancer10.3390/nano7070189 ↗
52. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging10.1016/j.jconrel.2016.03.030 ↗
53. YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells10.1007/s00280-018-3535-6 ↗
54. Mesoporous silica nanoparticles engineered for ultrasound-induced uptake by cancer cells10.1039/C8NR00693H ↗
55. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice10.1038/s41467-019-09760-3 ↗
56. Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy10.1016/j.biomaterials.2018.02.004 ↗
57. Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer10.1016/j.biomaterials.2017.05.025 ↗
58. Controllable synthesis of monodispersed NU-1000 drug carrier for chemotherapy10.1021/acsabm.9b00621 ↗
59. A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy10.1371/journal.pone.0040388 ↗
60. pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer–lipid bilayer10.1021/am403092m ↗
61. Microneedle-mediated delivery of lipid-coated cisplatin nanoparticles for efficient and safe cancer therapy10.1021/acsami.8b12926 ↗
62. Bioresorbable, miniaturized porous silicon needles on a flexible water-soluble backing for unobtrusive, sustained delivery of chemotherapy10.1021/acsnano.0c02343 ↗
63. Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model10.1016/j.ijpharm.2018.12.022 ↗
64. Drug coated microneedles for minimally-invasive treatment of oral carcinomas: development and in vitro evaluation10.1007/s10544-015-9944-y ↗
65. Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer10.1080/10717544.2018.1455760 ↗
66. Two-dimensional non-carbonaceous materials-enabled efficient photothermal cancer therapy10.1016/j.nantod.2016.05.009 ↗
67. Two-dimensional ultrathin MXene ceramic nanosheets for photothermal conversion10.1021/acs.nanolett.6b04339 ↗
68. Dissolving microneedles integrated with pH-responsive micelles containing AIEgen with ultra-photostability for enhancing melanoma photothermal therapy10.1039/D0BM00914H ↗
69. A two-dimensional biodegradable niobium carbide (MXene) for photothermal tumor eradication in NIR-I and NIR-II biowindows10.1021/jacs.7b07818 ↗
70. A two-dimensional MXene potentiates a therapeutic microneedle patch for photonic implantable medicine in the second NIR biowindow10.1039/D0NR01444C ↗
71. Metal–organic framework as a simple and general inert nanocarrier for photosensitizers to implement activatable photodynamic therapy10.1002/adfm.201707519 ↗
72. Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release10.1002/anie.201908997 ↗
73. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy10.1016/j.colsurfb.2018.10.019 ↗
74. An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging10.1016/j.biomaterials.2020.120089 ↗
75. Efficacy of 5-aminolevulinic acid in photodynamic detection and photodynamic therapy in veterinary medicine10.3390/cancers11040495 ↗
76. Selective killing of activated T cells by 5-aminolevulinic acid mediated photodynamic effect: potential improvement of extracorporeal photopheresis10.3390/cancers12020377 ↗
77. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor10.1016/j.jconrel.2018.07.038 ↗
78. 5-aminolevulinic acid-loaded hyaluronic acid dissolving microneedles for effective photodynamic therapy of superficial tumors with enhanced long-term stability10.1002/adhm.201900896 ↗
79. 5-Aminolevulinic acid coated microneedles for photodynamic therapy of skin tumors10.1016/j.jconrel.2016.08.015 ↗
80. 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer10.1111/iju.13291 ↗
81. Gene therapy leaves a vicious cycle10.3389/fonc.2019.00297 ↗
82. Cutaneous microenvironment responsive microneedle patch for rapid gene release to treat subdermal tumor10.1016/j.jconrel.2019.10.016 ↗
83. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment10.1016/j.ijpharm.2018.10.043 ↗
84. Local administration of siRNA through microneedle: optimization, bio-distribution, tumor suppression and toxicity10.1038/srep30430 ↗
85. DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system10.1016/j.ejpb.2018.02.029 ↗
86. Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations10.1038/nrd.2015.35 ↗
87. An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer10.1002/ajh.25418 ↗
88. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia10.1038/s41591-018-0010-1 ↗
89. Chimeric antigen receptor (CAR) T cell therapy in acute myeloid leukemia (AML)10.3390/jcm8020200 ↗
90. Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies10.1038/nrendo.2016.205 ↗
91. Toward biomaterials for enhancing immune checkpoint blockade therapy10.1002/adfm.201802540 ↗
92. Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors10.1016/j.intimp.2018.06.001 ↗
93. Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens10.1038/s41587-019-0390-x ↗
94. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation10.1038/s41587-019-0247-3 ↗
95. Neoantigen vaccine: an emerging tumor immunotherapy10.1186/s12943-019-1055-6 ↗
96. Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody10.1021/acs.nanolett.5b05030 ↗
97. Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors10.1021/acsnano.6b04989 ↗
98. A melanin-mediated cancer immunotherapy patch10.1126/sciimmunol.aan5692 ↗
99. Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells10.1038/s41467-019-11157-1 ↗
100. Dendritic cells and cancer: from biology to therapeutic intervention10.3390/cancers11040521 ↗